Literature DB >> 6953271

Breast cancer and serum cholesterol.

R A Hiatt, G D Friedman, R D Bawol, H K Ury.   

Abstract

Recent studies have suggested a role for dietary fat in the etiology of breast cancer. The relation of serum cholesterol and other serum lipid measures to breast cancer incidence was investigated in a cohort of 95, 179 women who had multiphasic health checkups from 1964 through 1972. Through 1977, 1,035 new breast cancer cases occurred in over 752,000 person-years of follow-up. Age-adjusted incidence rates were 1.45, 1.37, 1.31, and 1.40/1,000 person-years from the lowest to the highest quartile of serum cholesterol level, respectively. Similarly, no statistically significant relation was detected between beta-lipoprotein or total lipids and breast cancer. The sample size was sufficiently large to have detected a relative risk of 1.4 or larger with a probability of 99.9% at the 0.05 level of significance. The expected relation od breast cancer to established risk factors was confirmed by univariate analysis, and serum cholesterol and breast cancer were not associated after simultaneous consideration of nine other risk factors by multivariate analysis. These data suggest that the postulated causal relation between dietary fat and breast cancer does not act via an effect on circulating lipid levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6953271

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Fat and cancer.

Authors:  L J Kinlen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

Review 2.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

3.  Fat intake, obesity, and cancer of the breast and endometrium.

Authors:  A P Simopoulos
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

5.  Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Authors:  C C Zielinski; I Stuller; P Rausch; C Müller
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins.

Authors:  D Jain; A Ray; A K Bahadur; K U Chaturvedi; R Sood; S Sharma; S L Naik; B K Sharma
Journal:  Indian J Clin Biochem       Date:  2001-01

7.  Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women.

Authors:  M Gaard; S Tretli; P Urdal
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

8.  Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.

Authors:  C G Isles; D J Hole; C R Gillis; V M Hawthorne; A F Lever
Journal:  BMJ       Date:  1989-04-08

9.  Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.

Authors:  A M Strasak; R M Pfeiffer; L J Brant; K Rapp; W Hilbe; W Oberaigner; S Lang; W Borena; H Concin; G Diem; E Ruttmann; B Glodny; K P Pfeiffer; H Ulmer
Journal:  Ann Oncol       Date:  2009-01-22       Impact factor: 32.976

10.  A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

Authors:  Alicia Beeghly-Fadiel; Nikhil K Khankari; Ryan J Delahanty; Xiao-Ou Shu; Yingchang Lu; Marjanka K Schmidt; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Joe Dennis; Drakoulis Yannoukakos; Alison M Dunning; Paul D P Pharoah; Georgia Chenevix-Trench; Roger L Milne; David J Hunter; Hall Per; Peter Kraft; Jacques Simard; Douglas F Easton; Wei Zheng
Journal:  Int J Epidemiol       Date:  2020-08-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.